Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The entry "poly glycohydrolase pseudogene" (ENSG00000286793) is a *pseudogene*, which means it is a segment of DNA that resembles a gene but is non-functional and does not code for a protein. Pseudogenes do not generally produce functional products or participate in biological processes, molecular pathways, or disease mechanisms. No relevant information about protein function, therapeutic applicability, or chemical modulation exists for this entity. It should not be confused with the protein-coding, therapeutically relevant enzyme **Poly(ADP-ribose) glycohydrolase (PARG, ENSG00000227345)**, which is involved in poly(ADP-ribose) metabolism and DNA repair[1][3][4]. - "Pseudogene" denotes a gene relic without protein product or known biological function. - No evidence supports it as a drug or biomarker target; it is not a receptor, enzyme, transporter, or any other functional entity. - All relevant literature, biochemical pathways, and drugs refer to the functional PARG gene rather than the pseudogene. - The use of this pseudogene as a "target" name is likely incorrect, perhaps due to confusion with active PARG gene entries[1][3][4]. If you intended to inquire about the active target, the appropriate canonical entry would be **Poly(ADP-ribose) glycohydrolase (PARG, ENSG00000227345)**, a validated enzyme involved in DNA repair and cancer biology[1][3]. The pseudogene ENSG00000286793 is not a valid target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on poly glycohydrolase pseudogene.